-
Drug shortages and lean economic times might tempt some to scavenge the remnants of doses left in a "single-dose" vial.
-
On the surface, evacuating a facility might seem like a simple and straightforward process, but have you ever thought through exactly how you would evacuate patients, some of whom might be in surgery, as well as staff and families? Although such a scenario might seem far-fetched, consider these three recent examples:
-
A study by the University of Michigan (U-M) Health System in Ann Arbor showed 1 in 84 highest-risk patients suffers a dangerous blood clot after surgery.
-
A memo to the Centers from Medicare & Medicaid Services (CMS) from two leading surgeons on the literal cutting edge of infection prevention in the OR: Hospitals and federal regulators should encourage the use of newer and safer types of surgery and more transparency with patients on procedure options and possible outcomes.
-
-
-
From November 2003 to November 2005, 254 cases of childhood diarrhea and 452 age- and geographically-matched (by zip code) controls were enrolled in a case-control study of the etiology of acute diarrhea among children 10-49 months of age presenting to a pediatric emergency department.
-
At Duke University Health System, a tertiary-care medical center that has traditionally provided aggregated antimicrobial susceptibility data from both adult and pediatric isolates, antibiograms for Escherichia coli isolates from children ¡Ü12 years of age from July 2009 to September 2010 were developed and compared with antibiograms that combined adult and pediatric data. A total of 375 pediatric isolates were obtained from 327 patients.
-
An investigation initiated after a clinician reported to the Tennessee Department of Health on September 18, 2012 the case of a patient who developed meningitis due to Aspergillus fumigatus after having received an epidural corticosteroid injection at an ambulatory surgical center quickly identified a number of other suspect cases.
-
Sanofi Pasteur announced September 28, 2012 a recall of 6 lots of Typhim Vi polysaccharide vaccine, the injectable "killed" vaccine. A significant portion of the stock has been shown to be insufficiently immunogenic and at risk for "low antigen content."